SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000882796-04-000008
Filing Date
2004-03-10
Accepted
2004-03-10 17:56:58
Documents
3
Period of Report
2004-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 2425
3 powerofattny.htm EX-24 43
4 image002.jpg GRAPHIC 88902
  Complete submission text file 0000882796-04-000008.txt   93300
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 787 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 2127396400
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-23186 | Film No.: 04661176